We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VGR
676
DELISTED
Vector Group Ltd.
VGR
| $939K | 0.01% |
+136,680
| New | +$932K |
|
677
Clearwater Paper
CLW
$349M
| $934K | 0.01% |
24,612
+7,953
| +48% | +$285K |
|
678
BGC Group
BGC
$5.64B
| $920K | 0.01% |
+383,418
| New | +$1M |
|
|
ALTA
679
DELISTED
Altabancorp
ALTA
| $918K | 0.01% |
45,624
+5,898
| +15% | +$120K |
|
680
Werner Enterprises
WERN
$2.2B
| $910K | 0.01% |
+21,681
| New | +$960K |
|
681
Bankunited
BKU
$3.33B
| $908K | 0.01% |
41,421
-3,367
| -8% | -$71.4K |
|
682
Rayonier Advanced Materials
RYAM
$562M
| $903K | 0.01% |
282,292
-38,378
| -12% | -$124K |
|
|
AXLA
683
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $901K | 0.01% |
7,798
+5,244
| +205% | +$646K |
|
684
Precision BioSciences
DTIL
$178M
| $900K | 0.01% |
4,872
+516
| +12% | +$103K |
|
685
Voyager Therapeutics
VYGR
$181M
| $891K | 0.01% |
83,545
+20,419
| +32% | +$240K |
|
|
ZEUS
686
DELISTED
Olympic Steel
ZEUS
| $887K | 0.01% |
78,049
-8,170
| -9% | -$90.6K |
|
687
EQT Corp
EQT
$32.9B
| $881K | 0.01% |
68,100
+891
| +1% | +$13.1K |
|
|
FPRX
688
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $881K | 0.01% |
187,497
-29,494
| -14% | -$150K |
|
689
CrowdStrike
CRWD
$183B
| $873K | 0.01% |
25,416
-158,388
| -86% | -$4.61M |
|
690
Hamilton Beach Brands
HBB
$313M
| $868K | 0.01% |
44,607
-18,644
| -29% | -$320K |
|
|
CALA
691
DELISTED
Calithera Biosciences, Inc
CALA
| $866K | 0.01% |
12,549
-3,067
| -20% | -$268K |
|
692
Commercial Metals
CMC
$7.53B
| $862K | 0.01% |
+43,142
| New | +$897K |
|
693
Wabash National
WNC
$504M
| $852K | 0.01% |
71,238
-158,731
| -69% | -$1.87M |
|
694
Calix
CALX
$2.24B
| $848K | 0.01% |
47,715
-175,710
| -79% | -$3.32M |
|
695
Capital City Bank Group
CCBG
$897M
| $848K | 0.01% |
45,112
-8,925
| -17% | -$175K |
|
|
HTLF
696
DELISTED
Heartland Financial USA, Inc.
HTLF
| $845K | 0.01% |
28,170
-4,302
| -13% | -$138K |
|
|
SAFE
697
Safehold
SAFE
$1.17B
| $841K | 0.01% |
14,633
+10,387
| +245% | +$613K |
|
698
CarGurus
CARG
$3.34B
| $837K | 0.01% |
38,713
-4,126
| -10% | -$106K |
|
699
Harmonic Inc
HLIT
$1.15B
| $827K | 0.01% |
148,135
+59,962
| +68% | +$339K |
|
|
UFS
700
DELISTED
DOMTAR CORPORATION (New)
UFS
| $823K | 0.01% |
31,344
-36,418
| -54% | -$922K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.